The Microplasmin in Treatment of Ischemic Stroke – Intravenous (MITI-IV) trial, evaluated the safety and efficacy of intravenous microplasmin in 40 patients. There was no evidence of increased ...
The ReoPro Retavase Reperfusion of Stroke Safety Study (ROSIE) is an NIH-sponsored Phase II trial evaluating intravenous reteplase in combination with abciximab for the treatment of patients with ...
A recent study titled “Treatment of Ischemic Stroke by Atorvastatin-loaded PEGylated Liposome,” conducted by researchers at Chonnam National University Medical School and Hwasun Hospital ...
Napoleon Bunny Overview of the three approved SMO inhibitor drugs and their R&D pipeline From chloroquine to hydroxychloroquine, we should be cautious ab ...